Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

58.66
Delayed Data
As of Jul 29
 +0.23 / +0.39%
Today’s Change
45.69
Today|||52-Week Range
60.07
+11.06%
Year-to-Date
Investors Should Be Protective of Merck Gains
Jul 29 / TheStreet.com - Paid Partner Content
Merck (MRK) Beats on Q2 Earnings by a Penny
Jul 29 / Zacks.com - Paid Partner Content
Buy Merck on Near-Term Weakness
Jul 29 / TheStreet.com - Paid Partner Content
Stock Futures Mixed as Second-Quarter U.S. Growth Falls Short
Jul 29 / TheStreet.com - Paid Partner Content
Merck (MRK) Updates Outlook Following Q2 Earnings Beat
Jul 29 / Zacks.com - Paid Partner Content
Merck Shares Rise After Second-Quarter Earnings Top Forecasts
Jul 29 / TheStreet.com - Paid Partner Content
Agenus (AGEN) Posts Narrower than Expected Loss in Q2
Jul 29 / Zacks.com - Paid Partner Content
Merck (MRK) Stock Down Ahead of Q2 Earnings
Jul 28 / TheStreet.com - Paid Partner Content
S&P 500 and Nasdaq Turn Higher as Alphabet Leads, Exxon Falls
Jul 29 / TheStreet.com - Paid Partner Content
2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK
Jul 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close58.43
Today’s open59.01
Day’s range58.27 - 59.20
Volume8,491,237
Average volume (3 months)8,658,637
Market cap$161.7B
Dividend yield3.14%
Data as of 4:00pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+3.59%
Earnings growth (next 5 years)+5.05%
Revenue growth (last year)-7.92%
P/E ratio36.0
Price/Sales3.87
Price/Book3.64

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-3.53-0.39%
NVSNovartis+1.18+1.44%
BMYBristol-Myers Squibb+0.15+0.20%
SNYSanofi+0.03+0.07%
Data as of 4:02pm ET, 07/29/2016

Financials

Last reporting dateJuly 29, 2016
EPS forecast (this quarter)$0.91
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers

Search for Jobs